DJIA 17,094.46 -19.08 -0.11%
NASDAQ 4,474.93 18.92 0.42%
S&P 500 1,987.45 3.92 0.20%
market minute promo

Medivation, Inc. (NASDAQ: MDVN)

77.13 2.22 (2.96%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

MDVN $77.13 2.96%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $75.63
Previous Close $74.91
Daily Range $75.50 - $77.72
52-Week Range $48.15 - $88.20
Market Cap $5.9B
P/E Ratio -192.08
Dividend (Yield) $0.00 (0.0%)
Volume 783,024
Average Daily Volume 838,697
Current FY EPS $1.37

Sector

Healthcare

Industry

Drugs

Medivation, Inc. (MDVN) Description

A biopharmaceutical company engaged in the acquisition, research and development of promising medical technologies. Website: http://www.medivation.net/

News & Commentary

10 States Where Cancer Incidence Is the Highest

According to the CDC, these 10 states have the highest age-adjusted cancer incidence rates. Find out what some of the biggest risk factors are in these states as well as what therapies are being introduced to curb the rising tide of cancer diagnoses.

First Week of MDVN March 2015 Options Trading

Astellas Up on Pipeline Update, Oncology in Focus (revised) - Analyst Blog

Medivation Significantly Undervalued, With Xtandi Weeks Away From Prostate Cancer Label Expansion

Astellas Up on Pipeline Update, Oncology in Focus - Analyst Blog

Astellas Up on Pipeline Update, Oncology in Focus - Analyst Blog

Medivation Announces Change in Executive Management Team; Dawn Svoronos To Chief Commercial Officer

Medivation Set To Go Higher As Prostate Cancer Drug Xtandi Quickly Approaches Blockbuster Status

What Does Dendreon Need To Succeed?

3 Stocks Underperforming Today In The Health Care Sector

Aegis Capital Believes Seragon Deal Underscores Value In Medivation

UPDATE: Stifel Reiterates On Medivation Following Prostate Cancer Survey

See More MDVN News...

MDVN's Top Competitors

MDVN $77.13 (2.96%)
Current stock: MDVN
TMO $123.72 (0.54%)
Current stock: TMO
ILMN $178.39 (1.18%)
Current stock: ILMN
WAT $104.35 (-2.62%)
Current stock: WAT